Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Connection

Search Results to Yonglin Pu

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following properties of Pu, Yonglin

PropertyValue
keywords Metabolic tumor burden; metabolic tumor volume ; non-small cell lung cancer; FDG, PET/CT.
overview I am a board certified nuclear radiologist by the American Board of Nuclear Medicine, American Board of Radiology and American Board of Nuclear Cardiology. I am a reviewer of 16 international journals including Journal of Nuclear Medicine; European Journal of Nuclear Medicine and Molecular Imaging; Proceedings of the National Academy of Sciences (PNAS); International Journal of Computer Assisted Radiology and Surgery; PLOS ONE; Academic Radiology; Cancer Control Journal: Journal of the Moffitt Cancer Center; Medical Physics; International Journal of Radiation Oncology, Biology, Physics; Theranostics and Lung Cancer Management published by Future Medicine. I am an editorial board member of Chinese Journal of Cancer Research. I am also a reviewer of the Self-Assessment Module (SAM) for the American Board of Radiology. My research experience includes metabolic tumor imaging and quantification from FDG PET/CT imaging, and the impact of metabolic tumor burden on the long-term outcomes of patients with non-small cell lung cancer (NSCLC). I was the contact co-PI of an NIH (NCI) funded R21 project for developing the new PET volumetric prognostic (PVP) staging for NSCLC. My research experience also includes brain functional imaging and brain MRS as well as computer-aided diagnosis in PET/CT and bone scintigraphy. I have authored and co-authored more than 60 original peer-reviewed scientific research papers, six peer-reviewed proceeding papers, two non-peer-reviewed letters to editors and five non-peer-reviewed review papers in the field of medicine. I am the senior corresponding author of the article [Eur J Nucl Med Mol Imaging, 2012; 39(1): 27-38. https://www.ncbi.nlm.nih.gov/pubmed/21946983] that won the Springer Award in 2016 for the Most Cited Paper of the Eur J Nucl Med Mol Imaging (https://link.springer.com/article/10.1007/s00259-016-3538-7).

One or more keywords matched the following items that are connected to Pu, Yonglin

Item TypeName
Concept Lung Neoplasms
Academic Article Integrating PET and CT information to improve diagnostic accuracy for lung nodules: A semiautomatic computer-aided method.
Academic Article Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with non-small cell lung cancer.
Academic Article Prognostic value of the quantitative metabolic volumetric measurement on 18F-FDG PET/CT in Stage IV nonsurgical small-cell lung cancer.
Academic Article Prognostic value of tumor burden measurement using the number of tumors in non-surgical patients with non-small cell lung cancer.
Academic Article Interobserver variability among measurements of the maximum and mean standardized uptake values on (18)F-FDG PET/CT and measurements of tumor size on diagnostic CT in patients with pulmonary tumors.
Academic Article Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
Academic Article Independent prognostic value of whole-body metabolic tumor burden from FDG-PET in non-small cell lung cancer.
Academic Article Prognostic value of metabolic tumor burden in lung cancer.
Academic Article Relationship between Overall Survival of Patients with Non-Small Cell Lung Cancer and Whole-Body Metabolic Tumor Burden Seen on Postsurgical Fluorodeoxyglucose PET Images.
Academic Article A new PET/CT volumetric prognostic index for non-small cell lung cancer.
Academic Article Quantification of metabolic tumor activity and burden in patients with non-small-cell lung cancer: Is manual adjustment of semiautomatic gradient-based measurements necessary?
Academic Article Consistency of metabolic tumor volume of non-small-cell lung cancer primary tumor measured using 18F-FDG PET/CT at two different tracer uptake times.
Academic Article Prognostic value of quantitative PET/CT in patients with a nonsmall cell lung cancer and another primary cancer.
Academic Article Risk-stratifying capacity of PET/CT metabolic tumor volume in stage IIIA non-small cell lung cancer.
Academic Article PS01.47: PET Volumetric Prognostic Index may be the Most Significant Survival Factor in Non-Small Cell Lung Cancer Treated with Chemoradiation: Topic: Radiation Oncology.
Academic Article An updated and validated PET/CT volumetric prognostic index for non-small cell lung cancer.
Academic Article Developing and validating a novel metabolic tumor volume risk stratification system for supplementing non-small cell lung cancer staging.
Academic Article Whole body metabolic tumor volume is a prognostic marker in patients with newly diagnosed stage 3B non-small cell lung cancer, confirmed with external validation.
Grant Developing a PET Volumetric Staging System for NSCLC: a Complement to TNM Staging.
Academic Article The Relative Importance of Clinical and Socio-demographic Variables in Prognostic Prediction in Non-Small Cell Lung Cancer: A Variable Importance Approach.
Academic Article Developing a clinical and PET/CT volumetric prognostic index for risk assessment and management of NSCLC patients after initial therapy.

Search Criteria
  • Lung Cancer